Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-25 @ 4:10 AM
NCT ID:
NCT07086820
Eligibility Criteria:
Inclusion Criteria:
* Household contacts of patient (index case) with a new diagnosis of microbiologically confirmed pulmonary tuberculosis
* Age ≥5 to \<18 years old
Exclusion Criteria:
* Suspected active tuberculosis in initial assessment (clinical or radiological)
* Current pregnancy or breastfeeding
* Immunocompromised
* Allergy or contraindication to isoniazid or rifapentine
* Chronic liver disease or alcohol use disorder
* History of previous treatment for active or latent tuberculosis infection
* Previous tuberculin skin test
* Household contacts of a tuberculosis index patient with a known or suspected drug-resistant M. tuberculosis strain
* Household contacts or a tuberculosis index patient currently living away from home for more than four weeks
* Household contacts of a tuberculosis index patient who have already received more than 15 daily doses of antituberculous treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
17 Years
Study:
NCT07086820
Study Brief:
Protocol Section:
NCT07086820